Literature DB >> 23044801

Diabetes: inhibit VEGF-B to treat T2DM?

Fiona Mitchell.   

Abstract

Entities:  

Year:  2012        PMID： 23044801     DOI： 10.1038/nrendo.2012.195

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.

Authors:  Carolina E Hagberg; Annika Mehlem; Annelie Falkevall; Lars Muhl; Barbara C Fam; Henrik Ortsäter; Pierre Scotney; Daniel Nyqvist; Erik Samén; Li Lu; Sharon Stone-Elander; Joseph Proietto; Sofianos Andrikopoulos; Ake Sjöholm; Andrew Nash; Ulf Eriksson
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962
  1 in total
  1 in total

1.  miR-345-5p regulates adipogenesis via targeting VEGF-B.

Authors:  Xiaofeng Liu; Yang He; Zhaolan Feng; Jianjian Sheng; Aiwu Dong; Meiying Zhang; Lingling Cao
Journal:  Aging (Albany NY)       Date:  2020-09-14       Impact factor: 5.682
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.